ALDX Aldeyra Therapeutics Inc

Price (delayed)

$1.44

Market cap

$86.87M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.38

Enterprise value

$41.92M

?
Relative Growth: Rel. Growth: 14
Relative Strength: Rel. Strength: 4
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 12

A securities class action was filed in the United States District Court for the District of Massachusetts alleging that Aldeyra and certain officers made materially false and misleading statements about ...

Highlights
Aldeyra Therapeutics's debt has shrunk by 99% YoY and by 99% QoQ
The quick ratio has soared by 75% since the previous quarter and by 69% year-on-year
ALDX's equity is down by 31% year-on-year and by 10% since the previous quarter

Key stats

What are the main financial stats of ALDX

ALDX stock price

How has the Aldeyra Therapeutics stock price performed over time
Intraday
-5.26%
1 week
-9.43%
1 month
-25.39%
1 year
-73.18%
YTD
-72.2%
QTD
-32.39%

Financial performance

How have Aldeyra Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$24.07M
Net income
-$23.05M
Gross margin
N/A
Net margin
N/A
Aldeyra Therapeutics's operating income has surged by 55% YoY and by 15% QoQ
The net income has soared by 54% YoY and by 16% from the previous quarter

Price vs fundamentals

How does ALDX's price correlate with its fundamentals

Growth

What is Aldeyra Therapeutics's growth rate over time

Valuation

What is Aldeyra Therapeutics stock price valuation
P/E
N/A
P/B
2.29
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 55% YoY and by 16% QoQ
ALDX's price to book (P/B) is 52% less than its last 4 quarters average of 4.8 and 28% less than its 5-year quarterly average of 3.2
ALDX's equity is down by 31% year-on-year and by 10% since the previous quarter

Efficiency

How efficient is Aldeyra Therapeutics business performance
The return on assets has increased by 31% year-on-year and by 3.9% since the previous quarter
The ROE has grown by 28% YoY and by 7% from the previous quarter

Dividends

What is ALDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALDX.

Financial health

How did Aldeyra Therapeutics financials performed over time
The current ratio has surged by 81% since the previous quarter and by 72% year-on-year
The quick ratio has soared by 75% since the previous quarter and by 69% year-on-year
Aldeyra Therapeutics's debt is 100% lower than its equity
The company's debt to equity has shrunk by 100% QoQ and by 100% YoY
Aldeyra Therapeutics's debt has shrunk by 99% YoY and by 99% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.